Oral iron chelators.

Abstract

Deferoxamine (DFO) was the standard of care for transfusional iron overload for >40 years, requiring subcutaneous infusion for 8-12 h/day, 5-7 days/week. Oral iron chelators are an important development, offering the potential to improve compliance and patients' quality of life. The oral, three-times-daily agent deferiprone appeared to be a promising… (More)
DOI: 10.1146/annurev.med.60.041807.123243

6 Figures and Tables

Topics

  • Presentations referencing similar topics